These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9213629)

  • 21. Reverse pharmacognosy: another way to harness the generosity of nature.
    Blondeau S; Do QT; Scior T; Bernard P; Morin-Allory L
    Curr Pharm Des; 2010 May; 16(15):1682-96. PubMed ID: 20222859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacological evaluation of natural products--general and specific approaches to screening ethnopharmaceuticals.
    Malone MH
    J Ethnopharmacol; 1983 Aug; 8(2):127-47. PubMed ID: 6358706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interests and policies of the state of Sarawak, Malaysia regarding intellectual property rights for plant derived drugs.
    Chung FJ
    J Ethnopharmacol; 1996 Apr; 51(1-3):201-4. PubMed ID: 9213617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three decades of structure- and property-based molecular design.
    Müller K
    Chimia (Aarau); 2014; 68(7-8):472-82. PubMed ID: 25437386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The position of intellectual property rights in drug discovery and development from natural products.
    Boyd MR
    J Ethnopharmacol; 1996 Apr; 51(1-3):17-25; discussion 25-7. PubMed ID: 9213613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intellectual property protection in the natural product drug discovery, traditional herbal medicine and herbal medicinal products.
    Kartal M
    Phytother Res; 2007 Feb; 21(2):113-9. PubMed ID: 17117452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The pharmaceutical industry in France: the turning point of 1915].
    Bonnemain B
    Rev Hist Pharm (Paris); 2015 Dec; 63(388):399-422. PubMed ID: 26827550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful botanical research requires botanical expertise.
    Dentali SJ
    Clin Pharmacol Ther; 2010 Feb; 87(2):149-51. PubMed ID: 20107447
    [No Abstract]   [Full Text] [Related]  

  • 29. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceuticals from natural products: current trends.
    Seidl PR
    An Acad Bras Cienc; 2002 Mar; 74(1):145-50. PubMed ID: 11960183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural products as a resource for new drugs.
    Clark AM
    Pharm Res; 1996 Aug; 13(8):1133-44. PubMed ID: 8865302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triterpene sapogenins with oleanene skeleton: chemotypes and biological activities.
    Jatczak K; Grynkiewicz G
    Acta Biochim Pol; 2014; 61(2):227-43. PubMed ID: 24918494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and resupply of pharmacologically active plant-derived natural products: A review.
    Atanasov AG; Waltenberger B; Pferschy-Wenzig EM; Linder T; Wawrosch C; Uhrin P; Temml V; Wang L; Schwaiger S; Heiss EH; Rollinger JM; Schuster D; Breuss JM; Bochkov V; Mihovilovic MD; Kopp B; Bauer R; Dirsch VM; Stuppner H
    Biotechnol Adv; 2015 Dec; 33(8):1582-1614. PubMed ID: 26281720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioguided isolation of pharmacologically active plant components, still a valuable strategy for the finding of new lead compounds?
    Pieters L; Vlietinck AJ
    J Ethnopharmacol; 2005 Aug; 100(1-2):57-60. PubMed ID: 15996842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Studies on biodiversity of Vietnam and Laos" 1998-2005: examining the impact.
    Soejarto DD; Zhang HJ; Fong HH; Tan GT; Ma CY; Gyllenhaal C; Riley MC; Kadushin MR; Franzblau SG; Bich TQ; Cuong NM; Hiep NT; Loc PK; Xuan le T; Hai NV; Hung NV; Chien NQ; Binh le T; Vu BM; Ly HM; Southavong B; Sydara K; Bouamanivong S; Pezzuto JM; Rose WC; Dietzman GR; Miller BE; Thuy TV
    J Nat Prod; 2006 Mar; 69(3):473-81. PubMed ID: 16562860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The worldwide trend of using botanical drugs and strategies for developing global drugs.
    Ahn K
    BMB Rep; 2017 Mar; 50(3):111-116. PubMed ID: 27998396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patents of drugs extracted from Brazilian medicinal plants.
    Balbani AP; Silva DH; Montovani JC
    Expert Opin Ther Pat; 2009 Apr; 19(4):461-73. PubMed ID: 19441926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural products in the process of finding new drug candidates.
    Vuorelaa P; Leinonenb M; Saikkuc P; Tammelaa P; Rauhad JP; Wennberge T; Vuorela H
    Curr Med Chem; 2004 Jun; 11(11):1375-89. PubMed ID: 15180572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
    BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.